Stock Market News & Analysis
stocks
Bolt-on acquisition adds capabilities for undervalued ASX share
Shares are trading at a 61% discount to our fair value.
stocks
How to understand potential investments at a deeper level
Asking these simple questions can reveal valuable things about a company’s quality and economics.
stocks
ASX healthcare leader undervalued after share slump
The sell-off in this moated healthcare company ignores strong potential for revenue growth and margin improvement.
stocks
Our view on Xero’s big bet
The shares sold off after the announcement of the Melio Payments acquisitions.
stocks
10 cheap wide-moat US stocks for 2025
Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.
stocks
Ask the analyst: Why does the Santos story need to end like this?
Santos’ disappointing returns over the past twenty years are mostly a result of bad timing. The timing of its potential departure from the ASX could also be unfortunate.
stocks
Can a deep value approach work for individual investors?
Featuring what was probably the most interesting stock pitch at Morningstar’s recent conference for advisers.
stocks
A safer ASX insurance play
Why earnings may be more resilient in this corner of the insurance industry.
stocks
Undervalued ASX share despite headwinds
These shares with a strong dividend yield look attractive.
stocks
Ask the analyst: Why does Telstra have a moat and TPG doesn’t?
Being part of an oligopoly isn’t always enough to be awarded a moat by our analysts.
stocks
Bull or bear? Here’s how the outlook for US stocks stacks up
Headwinds and tailwinds are roughly in balance, but the outlook could tilt either way.
stocks
Expensive ASX star looks vulnerable to slowing sales growth
Cochlear’s biggest market segment has matured and it is looking elsewhere for growth.
stocks
Our thoughts on takeover bid for ASX energy major Santos
Unless regulators step in, the ASX looks set to lose another icon.
stocks
Big ASX IPO sees Bain cash in on Virgin at opportune time
We think Virgin’s offer price reflects benign industry conditions that are unlikely to remain so good forever.
of 236
Viewing 1 to 16 of 3775